Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125420391 | 12542039 | 1 | I | 20160630 | 20160708 | 20160708 | EXP | GR-ASTRAZENECA-2016SE72294 | ASTRAZENECA | 69.00 | YR | F | Y | 0.00000 | 20160708 | MD | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125420391 | 12542039 | 1 | PS | ANASTROZOLE. | ANASTROZOLE | 1 | Oral | U | U | 20541 | TABLET | ||||||||
| 125420391 | 12542039 | 2 | SS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | U | 0 | INJECTION | ||||||||
| 125420391 | 12542039 | 3 | SS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Oral | U | U | 0 | TABLET | ||||||||
| 125420391 | 12542039 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | U | 0 | |||||||||
| 125420391 | 12542039 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | ONCE A WEEK | U | U | 0 | ||||||||
| 125420391 | 12542039 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | ABRAXANE | U | U | 0 | ||||||||
| 125420391 | 12542039 | 7 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 8 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 9 | SS | EPIRUBICIN HCL | EPIRUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 10 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 11 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 12 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 13 | SS | NAVELBINE | VINORELBINE TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 14 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 15 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 16 | SS | LIPOSOMAL DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 17 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 125420391 | 12542039 | 18 | SS | ERIBULIN | ERIBULIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125420391 | 12542039 | 1 | Breast cancer metastatic |
| 125420391 | 12542039 | 2 | Breast cancer metastatic |
| 125420391 | 12542039 | 3 | Breast cancer metastatic |
| 125420391 | 12542039 | 4 | Breast cancer metastatic |
| 125420391 | 12542039 | 5 | Breast cancer metastatic |
| 125420391 | 12542039 | 6 | Breast cancer metastatic |
| 125420391 | 12542039 | 7 | Breast cancer metastatic |
| 125420391 | 12542039 | 8 | Breast cancer metastatic |
| 125420391 | 12542039 | 9 | Breast cancer metastatic |
| 125420391 | 12542039 | 10 | Breast cancer metastatic |
| 125420391 | 12542039 | 11 | Breast cancer metastatic |
| 125420391 | 12542039 | 12 | Breast cancer metastatic |
| 125420391 | 12542039 | 13 | Breast cancer metastatic |
| 125420391 | 12542039 | 14 | Breast cancer metastatic |
| 125420391 | 12542039 | 15 | Breast cancer metastatic |
| 125420391 | 12542039 | 16 | Breast cancer metastatic |
| 125420391 | 12542039 | 17 | Breast cancer metastatic |
| 125420391 | 12542039 | 18 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125420391 | 12542039 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125420391 | 12542039 | Acute lymphocytic leukaemia | |
| 125420391 | 12542039 | Breast cancer recurrent | |
| 125420391 | 12542039 | Malignant neoplasm progression | |
| 125420391 | 12542039 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |